Risperdal Lawsuit Pre Settlement Loans – Get Funding Today!
Risperdal lawsuit loans and pre settlement funding is now available for plaintiffs who’ve suffered from gynecomastia, a side effect of the harmful antipsychotic drug Risperdal (also known as Risperidone). If you can’t wait for your Risperdal case to settle, obtaining a cash advance on your pending lawsuit could help carry you over until your case settles.
If you’ve fallen on hard times and need financial assistance, Nova Legal Funding (NLF) can advance you cash before your Risperdal case settles. Waiting years for a payout is difficult, especially if bills are piling up as your injuries make it impossible to work. Also known as lawsuit loans, settlement funding is the solution to your financial problems.
If your Risperdal lawsuit already settled, you automatically qualify for funding. If your case is still pending, getting a cash advance on your future recovery is also very simple. To qualify for pre settlement funding on your Risperdal lawsuit, you or a loved one must have:
- been prescribed (and consumed) Risperdal within the last 15 years.
- been diagnosed with any of the following side effects: gynecomastia, stroke, substantial weight gain and diabetes.
- hired a lawyer to litigate your case on a contingency basis.
If you meet the above three-point criteria, you instantly qualify for the following terms and conditions from Nova Legal Funding:
- $500 to $100,000 in funding
- Zero risk agreement: repay nothing if you lose the case
- No upfront or monthly fees
- No credit checks
Risperdal lawsuits —how it started and where it is now
Risperdal is a potent second-generation antipsychotic drug that was approved by the FDA in 1993 (and again in 2006 with Invega) to treat schizophrenia. The drug is manufactured and marketed by Janssen Pharmaceutical, a sister company of Johnson & Johnson—one of the largest pharmaceutical companies in the world.
Risperdal was a cash-cow for Johnson & Johnson, bringing in billions of dollars in profits for the company. To increase those profits even more, J&J’s Janssen Pharmaceutical began advertising Risperdal for off-label uses in children. The FDA never approved the drug for such uses as described by Janssen, which ultimately landed them in hot waters with authorities. State and federal regulators went after Janssen for marketing Risperdal to children, and they won. On November 4th, 2014 , J&J agreed to pay more than 2.2 billion dollars in criminal and civil fines to settle the matter, according to the New York Times. U.S. Attorney General Eric Holder accused Johnson and Johnson directly, blaming them for taking advantage of the most “vulnerable individuals” in our society.
Unfortunately, the government’s efforts were too late. By the time the hammer came down, thousands of children and young adults were taking Risperdal. Victims who experienced horrendous and embarrassing side effects became plaintiffs, stepping forward with lawsuits claiming damages in the millions of dollars.
Side effects of Risperdal and Invega: gynecomastia and others
Young boys—and some adults—who took Risperdal for off-label use suffered from Gynecomastia, a traumatically-embarrassing condition that causes breast tissue enlargement in males. The condition often leads to a great deal of emotional and psychological damage. Besides the emotional damage, young men and boys often undergo an operation to resolve their enlarged breasts. Breast surgery, also known as a Mastectomy, has it’s own share of dangers.
In addition to Gynecomastia, Risperdal is also responsible for the following side effects:
- movement disorders: extrapyramidal symptoms (loss of control over movement) andtardive dyskinesia (involuntary, random and repetitive movements)
- diabetes: while patients with schizophrenia are already at an increased risk of type 2 diabetes, studies suggest that Risperdal and Invega heighten such a risk.
- heart problems and death: sudden cardiac death to an irregular heartbeat.
Risperdal verdicts and settlements (2012-2015)
Several cases have already gotten settled with J&J, some being confidential and others public. The first Risperdal personal injury lawsuit to go to trial was of 21 year old Aaron Banks, who began taking RIsperdal at age 9. His injuries included enlarged male breasts and a damaged endocrine system, leading to excessive weight gain and psychological deterioration. Aaron’s case settled in September 2012 but was kept confidential.
Ever since Aaron’s justified win, the number of settlements with J&J only grew. In January 2014, almost 8 plaintiffs reached a settlement (which was again confidential). In February 2015, Austin Pledger won the biggest public settlement against J&J for $2.5 million dollars.
Many plaintiffs who’ve suffered the same injuries described above are still waiting for their settlements to come. If you’re one of them but need money now, Nova Legal Funding can help you get a cash advance on your pending Risperdal case.
How big of a Risperdal lawsuit settlement loan do you qualify for?
The amount of money you can get advanced on your pending Risperdal claim depends on multiple factors related to your case. No matter what your situation, Nova Legal Funding provides a minimum of $2,500 and a maximum of $100,000 to Risperdal-related claims. Whether you qualify for the lower or higher end of that spectrum depends on the type of injury you sustained, and how long you were taking Risperdal medication for (among other factors).
Pre settlement loans of more than $10,000 are available for plaintiffs who were/are diagnosed with gynecomastia. If you suffered serious side effects after taking Risperdal and/or Invega and would like to know how much in settlement loans you qualify for, speak to a live representative in Nova Legal Funding by calling 800-760-0704.